BioAge Labs (BIOA) Interest & Investment Income (2023 - 2026)

BioAge Labs has disclosed Interest & Investment Income across 4 years of filings, most recently posting $3.4 million for Q2 2026.

• In Q2 2026, Interest & Investment Income rose 0.53% year-over-year to $3.4 million; the TTM figure through Jun 2026 stood at $12.7 million (down 4.58% YoY), while the FY2025 annual figure was $13.1 million, up 35.9% from the prior year.
• Interest & Investment Income came in at $3.4 million for Q2 2026 at BioAge Labs, up from $3.3 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $4.1 million in Q4 2024 to a low of $379000.0 in Q4 2023.
• Average Interest & Investment Income over 4 years is $2.5 million, with a median of $3.0 million recorded in 2025.
• Year-over-year, Interest & Investment Income soared 980.47% in 2024 and sank 31.82% in 2025.
• Over 4 years, Interest & Investment Income stood at $379000.0 in 2023, then soared by 980.47% to $4.1 million in 2024, then slumped by 31.82% to $2.8 million in 2025, then advanced by 23.14% to $3.4 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $3.4 million in Q2 2026, $3.3 million in Q1 2026, and $2.8 million in Q4 2025.